|
|
|
Leap Chem Co., Ltdis a supplier of
|
|
(3S,6Aβ,10bβ)-dodecahydro-3,4aα,7,7,10aα-pentamethyl-1H-naphtho[2,1-b]pyran-3β-acetaldehyde |
|
|
This listing includes other chemicals and chemical products supplied by Leap Chem Co., Ltd.
Click the line at a product and you will get the email form to send an inquiry.
|
|
|
Product names |
CAS numbers |
|
|
|
(3S,6R)-6-[(1R,3aR,4E,7aS)-4-[(2Z)-2-[(5R)-5-hydroxy-2-methylidene-cyc lohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-y l]-2-methyl-heptane-2,3-diol
55700-58-8
|
|
|
(3S,6R,7S,8S,12Z,15S,16E)-1,3,15-tris-{[tert-butyl(dimethyl)silyl]oxy}-7-hydroxy-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)heptadecyl-12,16-dien-5-one
193146-49-5
|
(3S,6R,7S,8S,12Z,15S,16E)-1,3,7,15-tetrakis-{[tert-butyl(dimethyl)silyl]oxy}-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)heptadeca-12,16-dien-5-one
193146-51-9
|
(3S,6R,7S,8S,12Z,15S,16E)-3,7,15-tris-{[tert-butyl(dimethyl)silyl]oxy}-1-hydroxy-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)heptadeca-12,16-dien-5-one
193146-53-1
|
(3S,6R,7S,8S,12Z,15S,16E)-3,7,15-tris-{[tert-butyl(dimethyl)silyl]oxy}-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)-5-oxo-heptadeca-12,16-dienoic acid
193146-63-3
|
(3S,6R,8S,9S,13R,14S,17R)-6-(Iodomethyl)-13-methyl-17-[(2R)-6-methylhe ptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[ a]phenanthren-3-ol
56897-09-7
|
|
|
|
|
|
|
|
|
|
(3S,6S)-4β-acetoxy-3,3aβ,4,5,6aβ,7,9aβ,9bα-octahydro-3β,9-dimethylspiro[azuleno[4,5-b]furan-6(2H),2'-oxiran]-2-one
35144-09-3
|
|
|
|
(3S,6S,12aS)-1,2,3,4,6,7,12,12a-Octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester
461054-93-3
|
(3S,6S,9R,12S)-6-(4-Aminobutyl)-12-benzyl-9-butan-2-yl-3-[(4-hydroxyph enyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexon e
99764-53-1
|
|
|
|
|
|
(3S,7R,10R,11R)-10-[(2R,3R,4R,5R,6S)-4-Amino-3,5-dihydroxy-6-methyl-oxan-2-yl]oxy-3,7,11-triethyl-1-azacyclotetradecan-2-one
135559-95-4
|
|
(3S,7R,8R,9R,10S,13R,14R,17R)-10-(Hydroxymethyl)-13-methyl-17-[(2R)-6-methyl-5-methylidene-heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodeca hydro-1H-cyclopenta[a]phenanthrene-3,7-diol
61737-96-0
|
(3S,7R,8S,9S,12Z,15S,16E)-3,8-bis[(tert-butyldimethylsilyl)oxy]-15-hydroxy-4,4,7,9,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)-6-oxoheptadeca-12,16-dienoic acid
193146-26-8
|
(3S,7S,8S,9S,10R,13R,14S,17R)-17-[(2R)-7-Hydroxy-6-methyl-heptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol
4725-24-0
|
(3S,8Aα)-2,3,4,5,6,7,8,8a-octahydro-3α,8,8-trimethyl-1H-3aα,6α-methanoazulen-7β-ol
86703-03-9
|
(3S,8Aα)-3β-[[2-(1,1-dimethyl-2-propenyl)-1H-indol-3-yl]methyl]-1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazine-1,4-dione
34610-68-9
|
(3S,8Ar,10S)-3-[[(E)-1,3-dihydro-3-oxo-2H-indol-2-ylidene]methyl]-1,2,3,7,8,8a-hexahydro-10-(1-methylethyl)-6H-3,8a-ethanopyrrolo[1,2-a]pyrazine-1,4-dione
38136-69-5
|
(3S,8Ar,10S)-3-[[(Z)-1,3-dihydro-3-oxo-2H-indol-2-ylidene]methyl]-1,2,3,7,8,8a-hexahydro-10-(1-methylethyl)-6H-3,8a-ethanopyrrolo[1,2-a]pyrazine-1,4-dione
38136-68-4
|
|
|
|
|
(3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-2,3,4,7,8,9,11,12,14,15-decahydr O-1H-cyclopenta[a]phenanthren-3-ol
1224-94-8
|
(3S,8R,9S,10R,13S,14S,16S)-3-Hydroxy-10,13-dimethyl-17-oxo-16-sulfooxy-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene
4873-65-8
|
|
(3S,8R,9S,10R,13S,14S,17R)-3,17-Dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-one
1159-66-6
|
(3S,8R,9S,10R,13S,14S,17S)-17-(bis-(2-Hydroxyethyl)amino)-10,13-dimethy L-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthre N-3-ol
6956-93-0
|
(3S,8R,9S,12S)-3,12-bis-(1,1-Dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-,2,5,6,10,13-pentaazatetradecanedioic acid 1,14-dimethyl ester
1292296-09-3
|
|
|
Information on Leap Chem Co., Ltd |
LEAPChem, a specialized fine chemicals supplier for research, development and production.
LEAPChem provides nearly 5,000 rare and innovative chemical products to support the evolving needs of our customers in research & bulk manufacturing activities.
As a highly customer-oriented enterprise, we are committed to providing high-quality customer services and products to our global customers in a cost-effective and efficient manner.
Our client list includes many major pharmaceutical and science companies, universities, research institutions and chemical catalogue companies.
Methodology: Sound and Stable;Active and Innovative.
Attitude: Conscientious; Ingenious.
Goals: Customer’s Satisfaction
We regard client’s success as our success.
At LEAPChem we strive to be the preferred supplier for efficiency increasing and cost lowering in your Research&Production.
To achieve this strategic vision, we always push ourself to exceed our customer's requirement. By focusing 'Beyond Your Expectation' we continually expand our product line, enhance our systematic management and human resources.
Welcome to contact us and we look forward to becoming your preferred partner.
|
Leap Chem Co., Ltd also offers: (3S,6Aβ,10bβ)-dodecahydro-3,4aα,7,7,10aα-pentamethyl-1H-naphtho[2,1-b]pyran-3β-acetic acid (3S,6Aβ,10bβ)-dodecahydro-3,4aα,7,7,10aα-pentamethyl-1H-naphtho[2,1-b]pyran-3β-acetaldehyde (3S,6Aα,10bα)-dodecahydro-3,4aβ,7,7,10aβ-pentamethyl-3β-vinyl-1H-naphtho[2,1-b]pyran (3S,6Aα,10bα)-dodecahydro-3,4aβ,7,10aβ-tetramethyl-3β-vinyl-1H-naphtho[2,1-b]pyran-7β-carboxylic acid methyl ester (3S,6Aα,10bα)-dodecahydro-3,4aα,7,7,10aβ-pentamethyl-3β-vinyl-1H-naphtho[2,1-b]pyran (3S,6Aα,10bα)-3α-ethyldodecahydro-3,4aβ,7,7,10aβ-pentamethyl-10H-naphtho[2,1-b]pyran-10-one (3S,6Aα,10bα)-3α-ethyldodecahydro-3,4aβ,7,10aβ-tetramethyl-1H-naphtho[2,1-b]pyran-7β-carboxylic acid methyl ester (3S,5S,E)-3,5-Dibromo-8-chloro-2,6-dimethyl-1,6-octadiene (3S,5S,8R,9S,10S,13S,14S,16R,17S)-17-(1-Hydroxyethyl)-10,13-dimethyl-2 ,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenan threne-3,16-diol (3S,5S,8R,9S,10S,13R,14S,16S)-3-Methoxy-10,13-dimethyl-2,3,4,5,6,7,8,9 ,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-16-ol (3S,5S,7S,13E,16S,17E,19R,21E)-5-ethyl-7,19-dihydroxy-3-[(R)-1-(1H-indol-3-yl)ethyl]-16,18-dimethyl-10,11-dinor[13]cytochalasa-6(12),13,17,21-tetrene-1,20,23-trione (3S,5S,6R)-tert-Butyl 3-bromo-2-oxo-5,6-diphenylmorpholine-4-carboxylate (3S,5S,6R)-3-[(3S)-4-Bromo-3-hydroxybutyl]-2-oxo-5,6-diphenyl-4-morpholinecarboxylic acid tert-butyl ester (3S,5S,6R)-3-[(3R)-4-Bromo-3-hydroxybutyl]-2-oxo-5,6-diphenyl-4-morpholinecarboxylic acid tert-butyl ester (3S,5S,6R)-3-amino-6-methyl-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-2-one hydrochloride (3S,5S,6R)-3-(3-Butenyl)-2-oxo-5,6-diphenyl-4-morpholinecarboxylic acid tert-butyl ester (3S,5S,6R)-2-Oxo-3-[2-(2S)-2-oxiranylethyl]-5,6-diphenyl-4-morpholinecarboxylic acid tert-butyl ester (3S,5S,6E)-O-tert-Butyl fluvastatin (3S,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid calcium salt (3S,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid (3S,5S,5'S)-3'α-(acetyloxy)-5-(3-furanyl)-2',3',4,5,6',7',8',8'aα-octahydro-4'aβ-(hydroxymethyl)-2'β-methyldispiro[furan-3(2H),1'(5'h)-naphthalene-5',2''-oxirane]-2,4'(4'ah)-dione (3S,5S,5'aS)-5-(3-furyl)-4,5,5',5'aβ,7',8',8'aα,8'b-octahydro-8'bα-hydroxymethyl-7'-methylenespiro[furan-3(2H),6'-[6h]naphtho[1,8-bc]furan]-2,2'(4'h)-dione (3S,5S,12R,19α,20S)-6,7-didehydro-3,20-epoxy-2β-methoxyaspidospermidine-3-carboxylic acid methyl ester (3S,5S,11E)-3,4,5,6,9,10-Hexahydro-5,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione (3S,5S,11E)-3,4,5,6,9,10-Hexahydro-3-methyl-5,14,16-tris(trimethylsilyloxy)-1H-2-benzoxacyclotetradecin-1,7(8H)-dione (3S,5S,10S,13R,17R)-4,4,10,13,14-Pentamethyl-17-propan-2-yl-2,3,5,6,7, 11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol (3S,5S,10S,13R,14S,17S)-5,14-Dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-3-[(2S,5R)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-ca (3S,5S,10S,13R,14S,17S)-3-[(2S,3S,4S,5R,6S)-3,4-Dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-oxan-2-yl]oxy-5,14-dihydroxy-13-methyl-17-(6-oxopyran-3-yl)-2,3 (3S,5S,10S,13R,14R,17R)-10,13-Dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol (3S,5S)-tert-Butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate (3S,5S)-Fluvastatin sodium salt (3S,5S)-Atorvastatin (sodium salt) (3S,5S)-5-[(1S,3S)-1-Azido-3-(hydroxymethyl)-4-methylpentyl]dihydro-3-(1-methylethyl)-2(3H)-furanone (3S,5S)-5-[(1S,2Z,3a?,10a?,10b?)-Decahydro-2-(2,5-dihydro-3-methoxy-4-methyl-5-oxofuran-2-ylidene)-1?-methyl-2H-furo[3,2-c]pyrrolo[1,2-a]azepin-8?-yl]-4,5-dihydro-3-methylfura (3S,5S)-5-Phenyltetrahydrofuran-3-yl acetate (3S,5S)-5-Methylpyrrolidin-3-ol (3S,5S)-3-Methyl-2,2-dioxo-2$l^{6},9-dithiabicyclo[4.3.0]nona-7,10-die N-5-ol (3S,5S)-3-Isopropyl-5-((2S,4S)-4-isopropyl-5-oxotetrahydro-furan-2-yl)-2-oxopyrrolidine-1-carboxylic acid tert-butyl ester (3S,5S)-3-Amino-5-hydroxy-piperidine-1-carboxylic acid tert-butyl ester (3S,5S)-3,5-Dimethylmorpholine hydrochloride (3S,5S)-3,5-Dimethylmorpholine (3S,5S)-3,5-bis[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-1-hydroxy-cyclohexanemethanol (3S,5S)-3,5-bis[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-1-hydroxy-cyclohexanecarboxylic acid methyl ester (3S,5S)-3,5-bis-(tert-Butyldimethylsilyloxy)-2-methylene-cyclohexanone (3S,5S)-3,5-bis-(tert-Butyldimethylsilyloxy)-2-methyl-1-cyclohexen-1-ol 1-trifluoromethanesulfonate (3S,5S)-3'-Hydroxycotinine (3S,5S)-3'-Hydroxycotinine (3S,5S)-2-Hexyl-3,5-dihydroxyhexadecanoic acid (3S,5S)-2-Azidomethyl-6-methoxy-tetrahydro-pyran-3,4,5-triol (3S,5S)-2,6-Dimethyl-3,5-heptanediol
|
|
|
|
|
|
|